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N 
~epe~~sio~ of a myocar~i~l infarct by t~,rom4o~ytic therapy 
is now wldejy used to limit infarct size (I ,2), preserve left 
ventricular function and improve survival (3-6). In some 
patients, however, throm~olytic therapy fails to recanalize 
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the infarct-related artery, whereas 
reecciusion (7.8). Assessment of the 
reperfusion after t~rombo~yt~c therapy is therefore an impor- 
taiit clinical question because persistent ischemia may mao- 
date further early interveation. 
Evaluation of the degree of reperfusion usually requires 
either coronary angiography or myocardial perfusion imag- 
ing with single photon emission computed tomography or 
positron emission tomography. A defect on perfusion imag- 
ing early after t~rom~o~yt~c therapy is usually taken to 
indicate: persistent or recurrent large coronary artery ob- 
struction. However, myocard;al perfusion may also fai! at 
the microvascular Level despite adequate patency of the 
infarct-related artery. 
II has been known for some years that blood 
be restored in some regions of the reperfuse 
observation that has been described as the “no reflow 
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phenomenon” (9-11). Although this phenomenon has been 
thought to result principally from events occurring during 
ischemia (10,12), there is evidence to indicate that regional 
no reflow is, in fact, a progressive phenomenon that devel- 
ops during the reperfusion period. Recent studies in our 
laboratory (13) have shown that regions exhibiting no reflow 
at 4 h after reperfusion did have reflow detectable by 
radionuclide-labeled microspheres during the initial period 
of reperfusion. This progressive loss of infarct perfusion is 
consistent with the hypothesis that neutrophil leukocytes 
cause microvascular occlusion in postischemic myocardium 
(14.15) and is supported by pathologic studies i 16) showing 
accumulation of neutrophils in the infarct zone during the 
first 24 h after reperfusion. 
The development of progressive microvascular occlusion 
and occurrence of the no reflow phenomenon should be 
detectable by radionuclide perfusion imaging. The precise 
time course of the development of the no reflow phenome- 
non and its appearance in myocardial reperfusion images 
are, however, uncertain. The positron-emitting nuclide ru- 
bidium-82 is a tracer of myocardial perfusion and has a short 
half-life (78 s), permitting sequential measurement of re- 
gional myocardial blood flow at short time intervals. This 
study therefore used rubidium-82 positron emission tomog- 
raphy to examine myocardial perfusion during 4 h of reper- 
fusion after 90 min of occlusion of the left anterior descend- 
ing coronary artery in anesthetized dogs. Measurements of 
regional infarct perfusion by rubidium-82 were compared 
with microsphere measurements of coronary flow and were 
subsequently correlated with pathologic measurements of 
infarct size and the extent of the no reflow zone. 
Experimental preparation. The care and treatment of all 
animals involved in this study were in accord with the 
Position of the American Heart Association on Research 
Animal Use, adopted November 1 I, 1984. The studies were 
performed in 12 dogs (I5 to 25 kg) anesthetized with thiamy- 
lal sodium (I8 mglkg body weight intravenously) and chlo- 
ralose (14 mglkg) in urethane (136 mg/kg intramuscularly). 
The dogs were ventilated with room air and supplemental 
oxygen (2 literslmin). Polyvinyl catheters were placed in 
both femoral veins for fluid and drug administration and in 
the !ight femoral artery for microsphere reference sampling. 
Afar a left thoracotomy, a catheter was also placed in the 
left atrium for microsphere injection and another in the left 
ventricle for pressure measurement. The proximal left ante- 
rior descending artery was then exposed and a pneumatic 
occluder placed loosely around the artery. This occluder was 
briefly inflated to ensure adequate occlusion of the artery 
and to confirm the extent of the ischemic risk region. The 
occluder was then deflated and the chest closed in layers 
with evacuation of residual p~eu~~tbor~~. The centerline of 
the left ventricle was the 
Reghra4 ~?~o~~l~dia~ blood flow I 
of 2 million sonicated 
pm diameter) labeled with one of 
(cerium-141, gadolinium- 
bium-95 or scandium-46; 
reference blood samp%e was w 
artery at 2.16 mllmin (17). An initial 
cardial blood flow was made during 
the pneumatic occluder 
lidocaine (1 mg/kg intravenous 
mg/kg intravenous@) to reduce the incidence 
arrhythmias during coronary oc 
ventricular pressure were co 
Brush 200). The left anterior 
uded for 90 min by inflation of the balloon occluder and 
aVL of the elec:rocardiogram (ECG) 
segment elevation. After 45 min of isc 
hemodynamic variables were stable, the d 
sitron emission tomography suite. 
yocdial ; erfusion i~~gi~~. y~ca~dia~ pe~~sio~ im- 
ages were obtained with a Neuro SCAT three-tin 
camera (CTI). which has an in-plane resolution of : 
an interslice distance of 32 mm. Each dog was placed on the 
camera table in a lateral position, with the left side upper- 
most. The dogs were positioned with a Laser reference 
system, so that the mid left ventricular plane was at the level 
of the middle detector ring of the camera. Intravenous 
infusion of rubidium-82 was used as a tracer of myocardial 
perfusion (18.19). The rubidium-82 was eluted from a porta- 
ble generator (Squibb) by infusion of 0.9% saline solution at 
a rate of 15 mllmin with a controlled speed pump. The 
duration of each infusion was 3 min, during which 20 to 40 
mCi of rubidium-82 was infused. An interval of at least IO 
min was allowed between each infusion to allow recovery of 
the generator. Perfusion images were acquired over a period 
of 2 min. commencing I min after the end of rubidium-82 
infusion. Initial perfusion images were acquired during the 
final 30 min of left anterior descending artery occlusion to 
locate the image plane that best illustrated the perfusion 
deficit, as well as normally perfused myocardium in the 
circumflex artery territory. Typically, this plane corre- 
sponded with the mid-ventricular indicator on the chest wall. 
Qnce the best image plane was d&red, the dog was not 
moved for the remainder of the study. 
After80 min ofischernia, radionuclide microspheres were 
again injected into the left atrium to measure collateral blood 
flow to the ischemic risk region. Each dog was then given a 
repeat intravenous injection of lidocaine (I mg/kg) and 
bretylium tosylate (5 mg!kg) before deflation of the balloon 
occluder after 90 min of &hernia. After 5 min of reperfusion, 
rubidium-82 imaging was repeared and regional myocardial 
blood flow measured by microspheres. Subsequently, rubid- 
ow were re 
graphed in color to re 
and infarct and no reflow zones as a ~ro~ort~o~ of left 
ventricular mass. 
After photography, myocardial samples (0.5 to 1.5 
were obtained from the infarcted, ischemic and ~oRische 
ions of each myocardial slice. These sa 
vided into endocardial, mid-wall and epicardial thirds, 
weighed and counted n a well spectrometer (model 5986. 
Hewlett-Packard) wit the reference blood samples with 
appropriate energy windows. gional myocardial blood 
flow (mllmin per g) was calculat by standard methods and 
corrected to account for the combined effects of microsphere 
nd hemorrhage (22). 
anaiaysis. The serial rubidium-82 images 
color on a large monitor screen without 
correction for attemmtion and were reviewed b 
ers. The same myocardial plane was used 
be observers placed rn~lt~~le 3 x 3 
8.3 mm) regions of interest in the nor 
regions on the initial perfusion image (Fig. I). Subsequent 
images were displayed in the same format, and the same 
regions of interest in the same positions were transferred to 
g coronary oc 
rder zones were not in 
The coeJ7icient of variation of rubidium-82 coirrit activity 
the ~~~~~~ regions of interest was 12.5 L 6.9% (mean 
f on the initial reperfusion image and Il.9 + 5.4% on 
Withes the ischemic zone, the co 
17.1 + 3.4%aand2 
initial and 4 h reflow images, res 
zone, the coefficient of variation of mean rubidium-82 count 
activity on serial images was 9.1 t 2.2%. ause the 
same myocardial regions were compared in h image, 
petiusion of the infarct zone was calculated relative to the 
normal zone as the ratio CiIC”. Similarly, relative blood ilow 
to the infarct zone measured by microspheres was calculated 
as the ratio cl mean transmural flow in the mjddle of the left 
anterior descending (Qi) and cjrcum~ex (0,) artery territo- 
ries. QilQn* 
reflow zone was termined by least squares re 
analysis, Results a 
p value ~I.015 is regarded as signifitint. 
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Table 1. Hemo(jynamics During Left Anterior Descending Coronary Artery Occlusion and Reperfusion n 12 Dogs 
Refiow 
Before 90 Min of 
lschemia lschemia 5 Min IW 3 
Heart rate (beats/min) 1302 5 135 2 6 141 f 6 138 + 4 139 + 5 
LV systolic pressure (mm Hg) 108 * 41 IO f 4 II324 II1 L 6 122 t 4 
LV diastolic pressure (mm Hg) 6-cl IO + 2* ID -c 2* IO + 2* 11 zk2* 
LAD flow (mUmin per g) 0.79 + 0.05 0. I I f 0.02+ ; j 2 0.14t 1.0 -c 0.11 0.65 I o.ostj: 
LCx flow (mYmin per g) 0.91 + 0.03 0.90 c 0.0s 0.94 If: 0.10 I.0 2 0.10 1.1 ” 0.13 
*p < 0.05 versus before ischemia: tp C 0.05 versus flow in the IeR circumflex artery (LCx): Sp < 0.05 versus 1 h reflow. Daia are mean values + SEM. 
Coronary flows are mean flows measured by microspheres. LAD = left anterior descending artery; LV = left ventricle. 
emodynamics. During the period ofcoronary occlusion 
and reperfusion, both heart rate and left ventricular systolic 
pressure were stable (Table I). There was a small increase in
left ventricular diastolic pressure during occlusion of the 
anterior descending artery, which persisted during the reper- 
fusicn period. Mean coronary flow in the circumflex artery 
territory was unchanged during left anterior descending 
artery occlusion and reperfusion. In the left anterior de- 
scending artery region, mean collateral flow during ischemia 
was 0.11 + 0.02 mllmin per g. During reperfusion, there was 
an initial hyperemia with Row of I .3 2 0.14 mkmin per g (p < 
0.05 versus preischemia). Subsequently, therewas a pro- 
gressive decrease in mean transmural coronary flow in the 
left anterior descending artery region to 0.65 2 0.05 mUmin 
per g after 3 h of reperfusion (p < 0.01 versus 5min of reflow 
and p < 0.05 versus circumflex flow at 3 h). 
Time COMW of myoca rfusion. In each dog, the 
ischemic anterior descending artery region was easily iden- 
tified on the rubidium-82 images and regions of interest 
assigned accordingly. After 5 min of reperfusion, the rubid- 
ium-82 perfusion deficit was no longer evident, but during 
the next 4 h, there was a gradual nd progressive r appear- 
ance of the perfusion deficit in each dog. A series of 
rubidium-82 perfusion images during occlusion and reflow of 
the left anterior descending artery is shown in Figure 2; each 
image was acquired in the same anatomic plane. The perfu- 
sion defect observed uring coronary occlusion resolved 
fully during early reflow, but then progressively reappeared 
over the next 4 h. After 4 h, the perfusion deficit appears 
similar to that observed during occlusion of the left anterior 
descending artery despite th  fact that the artery was freely 
patent during the reperfusion period. 
the 
The severiry of recwrent perjkion defects varied among 
dogs; the count activi:y profiles of two dogs are show in 
Figure 3. In the heart with the least severe recurrence of
perfusion deficit. regional left anterior descending artery 
perfusion exhibited a mild reduction during ~flow, with a 
mean CilC, ratio of 0.78 after 4 h. In contrast, the other heart 
exhibited progressive and severe hypoperfusion thr ughout 
the infarct region. In the center of the infarct, CJC, de- 
creased to a minimum ofO.14, with a mean CilC” ofO.31 after 
4 h of reflow. Among the 12 dogs, 3 had a mean C,IC, ratio 
~0.7 after 4 h, 4 had a mean CilC” ratio between 0.5 and 0.7 
and 5 had a mean Ci/C, ratio cO.5. 
T/W time coarse of changes in regional t~lyocardia~ per- 
Figure 2. Serial rubidium-82 images during isctemia and reperfu- 
sion of the left anterior descending artery territory. Images are 
shown for immediate reflow (u ~g~t) and after I, 2.3 and 4 b ef 
reperfusion. Despite resolutio be defect during early 
recurrent defect is observed between 2 and 4 h after rello 
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0.05 versus 5 min of 
p < 0.05 versus 2 h of 
owh After 2 h of re 
ipure 3, rubidium-8~ comet-activity refiles in the left anterior 
5 versus 2 h. p < t-LOS 
recurrence of pe~~s~on defects. A. With a 
small recurrent defe is initial hyperemia after release of the 
pe 
ere 
period. BY 4 h, perfusion in the center of the infarct is similar to that 
during p;oximA coronary occlusion. It is also of note that left 
anterior descending artery perfusion during coronary occlusion is 
less than that observed in A. 
pc~~sio~ was milde 
fkion on ~u~idi~~rn-8~ itnages is illusrrared for rhe group in 
Figure 4. During coronary occlusion. relative anterior de- 
scending perfusion measured by r~~idi~ -82 was 15 ~4% of 
circumflex artery perfusion. After relea of the occlusion, a 
prompt increase in the Ci/C” ratio to 0.97 +- 0.06 occurred. 
Subsequently, an inverse relation between the duration of 
reflow (time in minutes) and the Ci/C, ratio was observed 
(C,lC, = 0.9 - 0.0015 x time, r = -0.99, p < 0.001). The 
reduction in the C& ratio reiati to initial reflow was 
significant after I h of ~e~e~usio~. 
the mean CIIC, ratio h 
versus 5 min) and at 4 
2 h). A similar time-dep 
flows in the anterior d 
During initial reperfusion, relative flow to the anterior de- 
scending artery repion (QJQ,) was 1.47 2 0.15 (p < 0.01 
versus preocclusion), bu,t at 1 R, Qi/Q, was 1.08 + 0. L3 (P < 
5. Changes in regional myocardial blood flow measured by 
pheres in the postischemic left anterior descending &.ADI 
artery region before occlusion fREST), during occlusion (ISC) an& 
after 5 min and 1. 2 and 3 b of repercusion. A significant and 
progressive decrease in endocardial (ENDO) (open bars) and mid- 
wall (MID) (rr~ss-hatch bars) myocardial blood flow is observed 
during4 h ofreperfusion. The:e is only a s,nall decrease in epicardial 
(EPU flow (closed bars). Symbols as in Figure 4. 
REST SC 5 MIN 1 HR 2 HR 5 HR 
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Figure 6. A, Inverse relation between transmural collateral blood Figure 7. A. Inverse relation between residual ~e~Msio~ in the left 
flow measured by microspheres during left anterior descending anterior descending (LAD) artery infarct region measured by rubid- 
artery occlusion and infarct size (as a fraction of the risk region) ium-82 after 4 h of reperfusion and pathologic infarct size measured 
after 4 h of reperfusion (Y = 0.69 - 2.65X. r = -0.92, SEE = 0.09). by triphenyltetrazolium staining 0’ = 1.1 I - 1.24X, r = -0.88, 
B, Inverse relation between transmural collateral blood flow mea- SEE = 0.10). 5. Inverse relation between residual left anterior 
sured by microspheres and the extent of the no retlow zone (as a 
fraction of the risk region) after 4 h of reperfusion (Y = 0.62e-‘7.YX. 
descending artery region perfusion measured by rubidium-82 after 4 
h of reperfusion and the extent of the no reflow zone, measured by 
r = -0.90. SEE = 0.644). thiotlavin8 staining 0’ = 0.72 - 0.95X. r = -0.84, SEE = O.tO). 
where flow was 1.34 +. 0.17 ml/min per g at 5 min of 
reperfusion a d 0.55 St 0.05 ml/mm per g after 3 h (p < 0.01). 
The epicardial region displayed the least reduction i  coro- 
nary flow during reperfusion (1.33 + 0.12 mllmin per g after 
5 min to 0.97 + 0.13 mllmin per g after 3 h, p < 0.05). As a 
result, the endocardiaUepicardiaI flow ratio was reversed in 
the postischemic myocardium. The endocardiallepicardial 
ratio was 1.08 f 0.03 in the preischemic myocardium and at 
5 min of reperfusion it was 0.95 k 0.14. The endocardiall 
epicardial ratio then progressively decreased to 0.75 2 0.12 
after 2 h of reperfusion a d to 0.54 + 0.09 after 3 h (p C 0.01 
versus 5mitt). 
Infarct size and recurrent perfusion defects. Both infarct 
size and the extent of the no reflow region were inversely 
related to collateral coronary flow during occlusion of the 
left anterior descending artery (Fig. 6). Infarct size ranged 
from 5% to 63% of the risk region, whereas the extent of the 
no reflow zone ranged from 0.5% to 42% of the risk region. 
The extent of the no reflow zone in each heart was related to 
infarct size (no reflow/risk = 0.62 x infarct/risk, r = 0.77, 
P < 0.01). The largest infarcts and most extensive no r flow 
zones were observed in hearts with a collateral flow ~0.1 
mUmin per g. Residual myocardial perfusion in the infarct 
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RELATIVE LAD PERFUSION (Rb-BP) 
0.0 
region measured by rubidium-82 after 4 h of reperfusion 
exhibited an inverse reiation with both infarct size and the 
extent of the no reflow zone (Fig. 7). The variability in the 
severity of recurrent perfusion defects reflects differences in 
the size of the infarct and no reflow zones. The three hearts 
with a C&n ratio >0.70 at 4 h all had an infarct involving 
~20% of the risk region and all five hearts with a C/C, ratio 
CO.50 had an infarct >SO% of the risk region. 
This study demonstrates that, despite a patent infarct- 
related artery. microvascular perfusion to the postischemic 
myocardium becomes progressively impaired uring the first 
4 h of reperfusion. This impairment is manifest as the 
reappearance of a perfusion deficit on serial rubidium-82 
positron emission tomographic mages during the reflow 
period and a progressive decrease inendocardial nd mid- 
wall coronary flow as measured by microspheres. The 
perfusion deficit on rubidium-82 i 
extent of the no reflow zone in the infarct region, as 
indicated by thioflavin-S staining in postmortem yocardial 
specimens (IO). The severity of a perfusion defect on radio- 
JACC Vol. 16. lb. 3 
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eremia is reduce 
r 3 h sf ischemia. 
at near normal Lev 
the precapillary level, 
the capillary level and is affected by myocyte membrane 
exchange and cellular retention of the tracer. The uptake of 
rubidium-82 may therefore be reduced in necrotic myocar- 
dium. In addition, unli res, the extraction frac- 
tion of most diffusible radicnucl tracers such as rubidium- 
82 decreases at high flow rates (28). The 
extraction fraction may be further reduced in myocardium 
reperfused after a prolonged period of ischemia (291. Thus, 
rubidium-82 may underestimate myocardia~ perfusion when 
coronary flow rates are increase 
Other factors, including tracer 
volume effects due to a thinne netic left ventric- 
ular wall (311, may Bso sontribute to underestimation of 
hyperemic coronary w with rubidium-82. 
The difference between rubidium-82 and microsphere 
measurements of myocardial perfusion did, however, de- 
crease during the reperfusion period. The likely reasons for 
the coronary occhtsi 
maguitude is reduced in a reperfused infarct because of 
myocardial edema and vascular disruption (24,259. The 
present observation of e hyperemic flow of only 1.5 
sed left anterior descending 
artery region is consistent with this. Although ~eso~Mt~o~ of 
reactive hyperemia may contribute to the decrease in infarct 
perfusion observed within the 1st &our after reflow, it is 
unlikely to be the cause of the progressive de * 
rny~c~r~~a~ perfusion to slrbnormal levels between 
qfprogn3sive ~?ypQ~~~~s~o~ 09 
rhe posk$w9~~ic rnyomdiu9~~ is 111051 likely ~~~~~e~o~~n~~~ 
$he li0 ;ejIou- phc”ROtW;XEL As described by Krug (9) an 
loner (10) and their coworkers, the 
IS manifest as an absence of microva 
of perfusion staining within the i 
injection studies (13) have shown that the no reflow Zones 
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are characterized by abrupt vascular occlusion at both small 
arteriolar and venular levels and absent capillary filling. 
Histologic examiiiation (33) reveals endothelial and capillary 
disruption, extravasation of erythrocytes and extensive my- 
ocyte necrosis. Electron microscopy (13,34) has shown that 
myocyte contraction band necrosis i  present within the no 
reflow zone, indicating that hese zones must have r ceived 
some initial reperfusion before capillary obstruction OC- 
cut-red. This observation is supported by measurements of 
regional coronary flow with microspheres (13). which show 
that the areas of no reflow were perfused during the initial 
reflow period but subsequently lost perfusion over the next 
4 h. 
The cause of the no reflow phenotnenon retnaitos ttttcer- 
rain, but possibilities include endothelial swelling and myo- 
cardial edema (33,34), microthrombi (35) and neutrophil 
plugging (36,37). Considerable evidence supports a rule for 
neutrophil leukocytes in the pathogenesis of the no reflow 
phenomenon. In postischemic myocardium, endothelial 
damage and complement activation result in adherence of 
neutrophils tothe endothelium of small venules and capil- 
laries, with subsequent vascular occlusion and accumulation 
of erythrocyte and fibrin plugs (14,15,36-38). Histologic 
studies (16,39) show that marked infiltration ofpostischemic 
myocardium by neutrophils occurs over the first 24 h after 
reperfusion. Further support for the role of neutrophils n the 
no reflow phenomenon is provided by studies (21) showing 
that the extent of the no reflow zone can be reduced by 
reperfusion with neutrophil-depleted blood. 
Clinical implications. In the clinical setting, there is a 
need for reliable information about perfusion of the ischemic 
risk region after initial measures to recanalize the infarct- 
related artery are compiete. positron emission tomography, 
which allows evaluation ofboth myocardial biood flow and 
metabolism (40-42). has been advocated as a means for 
determining myocardial viability after thrombolysis (43-47). 
Persistent glucose metabolism in the infarct region indicates 
the existence ofviable myocardium, which may demonstrate 
improved function after reperfusion (4548). Furthermore, 
the observation f continued glucose metabolism in the risk 
region in the presence of a persistent myocardial perfusion 
defect suggests residual ischemic but viable myocardium. 
Such a perfusion/metabolism mismatch may therefore indi- 
cate a need for further efforts at recanalization of the 
infarct-related artery (44,45). 
The mtlts of rhe present stady have implications for the 
interpretation of residual perfttsion defects within the infarct 
re@‘on. A perfusion defect on a radionuclide image obtained 
at 2 to 4 h after eperfusion does not necessarily mean that 
the epicardial rtery has failed to recanalize or has reoc- 
eluded. A perfusion deficit may be present, even in the 
Presence ofa widely patent infarct-related artery, because of
miCrOvaSCUlar occlusion. The reperfused myocardium ay 
well continue to exhibit preferential utilization of glucose, 
resulting in a pe~usion~metab~lism mismate 
because of the rapid evo~otio~ of the no reflow 
a single myocardial reperfusion image does not fuI 
terize infarct perfusion. Serial imaging with short 
fusion tracers uch as rubidium-g2 or oxygen-l.%labe,eled 
water is therefore desirable. Because the no reflow phenom- 
enon is most prominent in large infarcts, the clinical situa- 
tions in which it is most likely to evolve are in those patients 
with prolonged coronary occlusion, a la 
low collateral coronary flow. Patients 
and early ~e~e~~sio~ woul less likely to manifest 
significant microvascular occlusion in t risk region. 
Comparison of se images obtained 
during the first I to 2 h after reperfusion wi 
obtaimed at3 to 4 h of reperfusion should allow 
tion of persistent infarct-related artery occbrsion from reper- 
fusion with subsequent o reflow. discrimination between 
infarct-related artery occlusion and microv 
tion after 4 h of repe.rfusion would be more 
titation of the severity of the perfusion defect on the later 
radionuclide images may be of help. The present results 
suggest that a defect resulting from infarct-related artery 
occlusion will have an infarct zone perfusion <20% of the 
normal zone perfusion. In contrast, most defects resulting 
from the no reflow phenomenon will have an infarct region 
perfusion >3O% of the normal zone perfusion, reflecting 
preservation of coronary flow in the epicardial layer of the 
reperfused infarct. 
Co~c~~sio~. After recanahzation of the infarct-related 
artery, the appearance of rubidium-82 perfusion images 
undergoes a rapid evolution, with progressive reappearance 
of the perfusion defect 1 to 2 h after reflow. This recurrent 
perfusion defect in the presence of a patent infarct-related 
artery is most likely due to microvascular occlusion and the 
no re9ow phenomenon. Serial radionuclide perfusion imag- 
ing and quantitation of regional myocardial perfusion are 
necessary to differentiate the perfusion defect resulting from 
a large coronary artery occlusion from the defect associated 
with microvascular obstruction. 
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